Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Long-Term Debt Repayments (2021 - 2025)

Biodesix's Long-Term Debt Repayments history spans 5 years, with the latest figure at $5000.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments fell 61.54% year-over-year to $5000.0; the TTM value through Dec 2025 reached $21000.0, down 58.82%, while the annual FY2025 figure was $21000.0, 58.82% down from the prior year.
  • Long-Term Debt Repayments reached $5000.0 in Q4 2025 per BDSX's latest filing, up from $4000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $25.4 million in Q1 2021 to a low of $3000.0 in Q2 2021.
  • Average Long-Term Debt Repayments over 5 years is $3.7 million, with a median of $12000.0 recorded in 2023.
  • The largest YoY upside for Long-Term Debt Repayments was 100366.67% in 2022 against a maximum downside of 99.96% in 2022.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $20.0 million in 2021, then increased by 17.81% to $23.6 million in 2022, then tumbled by 99.94% to $13000.0 in 2023, then changed by 0.0% to $13000.0 in 2024, then crashed by 61.54% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Long-Term Debt Repayments are $5000.0 (Q4 2025), $4000.0 (Q3 2025), and $5000.0 (Q2 2025).